news
02-26-2013, 12:13 AM
Encouraged by Rwanda’s steady gains in curbing measles, donors are paying for a more expensive dual vaccine that will target rubella, too.http://rss.nytimes.com/c/34625/f/642565/s/28f3c12c/mf.gif
http://da.feedsportal.com/r/158873256503/u/79/f/642565/c/34625/s/28f3c12c/a2.img (http://da.feedsportal.com/r/158873256503/u/79/f/642565/c/34625/s/28f3c12c/a2.htm)http://pi.feedsportal.com/r/158873256503/u/79/f/642565/c/34625/s/28f3c12c/a2t.img
More... (http://www.nytimes.com/2013/02/26/health/after-measles-success-rwanda-to-get-rubella-vaccine.html?partner=rss&emc=rss)
http://da.feedsportal.com/r/158873256503/u/79/f/642565/c/34625/s/28f3c12c/a2.img (http://da.feedsportal.com/r/158873256503/u/79/f/642565/c/34625/s/28f3c12c/a2.htm)http://pi.feedsportal.com/r/158873256503/u/79/f/642565/c/34625/s/28f3c12c/a2t.img
More... (http://www.nytimes.com/2013/02/26/health/after-measles-success-rwanda-to-get-rubella-vaccine.html?partner=rss&emc=rss)